Anti-p53 autoantibody as early diagnostic and prognostic marker of bronchogenic carcinoma in smokers
Background Mutations in the tumor protein 53 (TP53) gene can lead to expression of mutant p53 proteins that accumulate in cancer cells and can induce circulating p53 antibodies in patients with cancer. Neoplastic transformation leads to elevated plasma sialic acid concentration through shedding or s...
Main Authors: | Mohammed B.M Sofyan, Mohammad S.A Bakheet, Mostafa M.M Alomairi, Hamada Kawshtysayed, Sameh Salahelden |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Al-Azhar Assiut Medical Journal |
Subjects: | |
Online Access: | http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2018;volume=16;issue=3;spage=286;epage=295;aulast=Sofyan |
Similar Items
-
TP53 GENE MUTATIONS – FROM GUARDIAN OF THE GENOME TO ONCOGENE
by: Petar Babović, et al.
Published: (2010-03-01) -
The Underestimated Role of the p53 Pathway in Renal Cancer
by: Alessandra Amendolare, et al.
Published: (2022-11-01) -
p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
by: You-Na Sung, et al.
Published: (2022-12-01) -
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
by: Paola Monti, et al.
Published: (2020-10-01) -
Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)